speb/financial-data huggingface dataset:
APLI.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1125049.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1125049.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: 0.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Cash Financial: 1125049.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -42283.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 0.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -6356.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 41612.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -129864.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 1155585.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 1067333.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 1164685.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -48639.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 42323359.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -14628825.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 1884715.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Current Debt: 11648558.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 11648558.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 15825767.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Depreciation: 3616.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 3616.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 3616.00
APLI.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 121266120.00
APLI.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.01
APLI.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -1249581.00
APLI.TO income_statement (quarterly, 2025-06-30) — EBIT: -732656.00
APLI.TO income_statement (quarterly, 2025-06-30) — EBITDA: -729040.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -54556.00
APLI.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 1125049.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -42283.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -6356.00
APLI.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 319900.00
APLI.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 642469.00
APLI.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 486066.00
APLI.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 486066.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -12985.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: -2277067.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 0.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 703200.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 703200.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -29298.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 11226709.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -319390.00
APLI.TO income_statement (quarterly, 2025-06-30) — Net Income: -1249581.00
APLI.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -1249581.00
APLI.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -1249581.00
APLI.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -1249581.00
APLI.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -1249581.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -1249581.00
APLI.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -1249581.00
APLI.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -486066.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -29298.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -29298.00
APLI.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -486066.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 15427.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 0.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -14628825.00
APLI.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -1048940.00
APLI.TO income_statement (quarterly, 2025-06-30) — Normalized Income: -1521496.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -6356.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -319390.00
APLI.TO income_statement (quarterly, 2025-06-30) — Operating Income: -1052556.00
APLI.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 121266120.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 1179038.00
APLI.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 642469.00
APLI.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 319900.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 473570.00
APLI.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -550886.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Other Receivables: 425314.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Payables: 4177209.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 4177209.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 244378.00
APLI.TO income_statement (quarterly, 2025-06-30) — Pretax Income: -1218722.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: 0.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 515288.00
APLI.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 3616.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -29298.00
APLI.TO income_statement (quarterly, 2025-06-30) — Research And Development: 960973.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -72967389.00
APLI.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 642469.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 121266120.00
APLI.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 18096.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -14628825.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -14628825.00
APLI.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 47985.00
APLI.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 30859.00
APLI.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
APLI.TO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 89974.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 1900142.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -13925625.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 12351758.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -14628825.00
APLI.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 1052556.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 16528967.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 15427.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 703200.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 15602.00
APLI.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 319900.00
APLI.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 319900.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: -13941052.00
APLI.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 1179511.00
APLI.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 103935.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 4122928.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 15462347.00
APLI.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 121266120.00
APLI.TO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.01
APLI.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1125049.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 42323359.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 348679.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 348679.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Cash Financial: 348679.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -77415.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 0.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -759376.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -39083.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 52374.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: 313695.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 326986.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 303695.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -836791.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 42323359.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -15606315.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 742276.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Current Debt: 11613647.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 11613647.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 15751773.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Depreciation: 3245.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 3245.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 3245.00
APLI.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 121266120.00
APLI.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.01
APLI.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -989065.00
APLI.TO income_statement (quarterly, 2025-09-30) — EBIT: -1075576.00
APLI.TO income_statement (quarterly, 2025-09-30) — EBITDA: -1072331.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 60421.00
APLI.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 348679.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -77415.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -759376.00
APLI.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -96962.00
APLI.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 564228.00
APLI.TO income_statement (quarterly, 2025-09-30) — Interest Income: 218439.00
APLI.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 218439.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Cff: -47324.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: -3383668.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 0.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 609000.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 609000.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -30091.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 11873968.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -204923.00
APLI.TO income_statement (quarterly, 2025-09-30) — Net Income: -989065.00
APLI.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -989065.00
APLI.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -989065.00
APLI.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -989065.00
APLI.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -989065.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -989066.00
APLI.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -989065.00
APLI.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: 218439.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -30091.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -30091.00
APLI.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 218439.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 12182.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -15606315.00
APLI.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -975369.00
APLI.TO income_statement (quarterly, 2025-09-30) — Normalized Income: -906647.30
APLI.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -759376.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -204923.00
APLI.TO income_statement (quarterly, 2025-09-30) — Operating Income: -1075576.00
APLI.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 103935.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 121266120.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 564434.00
APLI.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 564228.00
APLI.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: -96962.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 92806.00
APLI.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -217550.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 149706.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Payables: 4138126.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 4138126.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 192004.00
APLI.TO income_statement (quarterly, 2025-09-30) — Pretax Income: -954099.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 201593.00
APLI.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 3245.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -30091.00
APLI.TO income_statement (quarterly, 2025-09-30) — Research And Development: 832833.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -73956455.00
APLI.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 564228.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 121266120.00
APLI.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 11576.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -15606315.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -15606315.00
APLI.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -14544.30
APLI.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 34966.00
APLI.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
APLI.TO balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 51887.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 754458.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -14997315.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 12222647.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -15606315.00
APLI.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 1179511.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 16360773.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 12182.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 609000.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 15198.00
APLI.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -96962.00
APLI.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -96962.00
APLI.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: -15009497.00
APLI.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 841905.00
APLI.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 114981.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 4447016.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 15415403.00
APLI.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 128366120.00
APLI.TO income_statement (quarterly, 2025-12-31) — Basic EPS: -0.01
APLI.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 348679.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 42486659.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 212754.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 212754.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 212754.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 149500.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -279835.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 334252.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 48314.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 22434.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 405000.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 24634.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -130335.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 42486659.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -16384943.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 535603.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 11723679.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 11723679.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 16196056.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Depreciation: -1.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: -1.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: -1.00
APLI.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 128366120.00
APLI.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.01
APLI.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -949502.00
APLI.TO income_statement (quarterly, 2025-12-31) — EBIT: -561491.00
APLI.TO income_statement (quarterly, 2025-12-31) — EBITDA: -561491.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -5590.00
APLI.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 212754.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 149500.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -279835.00
APLI.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 165433.00
APLI.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 256956.00
APLI.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 378193.00
APLI.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 378193.00
APLI.TO income_statement (quarterly, 2025-12-31) — Interest Income: 0.00
APLI.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 0.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -13235.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: -3924464.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 0.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 736800.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 736800.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -565.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 12247725.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 117637.00
APLI.TO income_statement (quarterly, 2025-12-31) — Net Income: -949502.00
APLI.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -949502.00
APLI.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -949502.00
APLI.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -949502.00
APLI.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -949502.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -953026.00
APLI.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -949502.00
APLI.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -378193.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -565.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -565.00
APLI.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -378193.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 12310.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 0.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -16384943.00
APLI.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -726924.00
APLI.TO income_statement (quarterly, 2025-12-31) — Normalized Income: -1090120.05
APLI.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -279835.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 117637.00
APLI.TO income_statement (quarterly, 2025-12-31) — Operating Income: -726924.00
APLI.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 114981.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 128366120.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 622476.00
APLI.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 256956.00
APLI.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 165433.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 139457.00
APLI.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 9613.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 124853.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Payables: 4472377.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 4472377.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 143690.00
APLI.TO income_statement (quarterly, 2025-12-31) — Pretax Income: -939684.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 0.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 179159.00
APLI.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: -1.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -565.00
APLI.TO income_statement (quarterly, 2025-12-31) — Research And Development: 575336.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -74909481.00
APLI.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 256956.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 128366120.00
APLI.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 11098.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -16384943.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -16384943.00
APLI.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 24814.95
APLI.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 9818.00
APLI.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
APLI.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 54306.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 547913.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -15648143.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 12460479.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -16384943.00
APLI.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 841905.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 16932856.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 12310.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 736800.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 25361.00
APLI.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 165433.00
APLI.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 165433.00
APLI.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: -15660453.00
APLI.TO income_statement (annual, 2026-03-31) — +Operating Expense: 4065321.00
APLI.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 974580.00
APLI.TO income_statement (annual, 2026-03-31) — +Total Revenue: 244179.00
APLI.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 25263.00
APLI.TO balance_sheet (annual, 2026-03-31) — Accounts Payable: 6303898.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 6303898.00
APLI.TO balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 15484065.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 15484065.00
APLI.TO cash_flow (annual, 2026-03-31) — Beginning Cash Position: 1228244.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 212754.00
APLI.TO balance_sheet (annual, 2026-03-31) — Capital Stock: 42491274.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 42491274.00
APLI.TO balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 40003.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 40003.00
APLI.TO balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 40003.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 40003.00
APLI.TO cash_flow (annual, 2026-03-31) — Cash Dividends Paid: 0.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 0.00
APLI.TO balance_sheet (annual, 2026-03-31) — Cash Financial: 40003.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Cash Financial: 40003.00
APLI.TO cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Financing Activities: 151149.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 121347.00
APLI.TO cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Investing Activities: 0.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 0.00
APLI.TO cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Operating Activities: -1337412.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -291845.00
APLI.TO cash_flow (annual, 2026-03-31) — Change In Payables And Accrued Expense: 2233047.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 1896266.00
APLI.TO cash_flow (annual, 2026-03-31) — Change In Prepaid Assets: -6089.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 23087.00
APLI.TO cash_flow (annual, 2026-03-31) — Change In Receivables: -130981.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: -1622695.00
APLI.TO cash_flow (annual, 2026-03-31) — Change In Working Capital: 2095977.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 296658.00
APLI.TO cash_flow (annual, 2026-03-31) — Changes In Account Receivables: -132481.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -1625495.00
APLI.TO cash_flow (annual, 2026-03-31) — Changes In Cash: -1186263.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -170498.00
APLI.TO balance_sheet (annual, 2026-03-31) — Common Stock: 42491274.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 42491274.00
APLI.TO balance_sheet (annual, 2026-03-31) — Common Stock Equity: -17331490.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -17331490.00
APLI.TO cash_flow (annual, 2026-03-31) — Common Stock Issuance: 277500.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 100000.00
APLI.TO balance_sheet (annual, 2026-03-31) — Current Assets: 1962460.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 1962460.00
APLI.TO balance_sheet (annual, 2026-03-31) — Current Debt: 12264765.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Current Debt: 12264765.00
APLI.TO balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 12264765.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 12264765.00
APLI.TO balance_sheet (annual, 2026-03-31) — Current Liabilities: 18633409.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 18633409.00
APLI.TO cash_flow (annual, 2026-03-31) — Depreciation: 8084.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Depreciation: 1224.00
APLI.TO cash_flow (annual, 2026-03-31) — Depreciation Amortization Depletion: 8084.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1224.00
APLI.TO cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 8084.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1224.00
APLI.TO income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: -4240740.00
APLI.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -1049067.00
APLI.TO income_statement (annual, 2026-03-31) — EBIT: -2418684.00
APLI.TO income_statement (quarterly, 2026-03-31) — EBIT: 62789.00
APLI.TO income_statement (annual, 2026-03-31) — EBITDA: -2410600.00
APLI.TO income_statement (quarterly, 2026-03-31) — EBITDA: 64013.00
APLI.TO cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: -1978.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -2253.00
APLI.TO cash_flow (annual, 2026-03-31) — End Cash Position: 40003.00
APLI.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 40003.00
APLI.TO cash_flow (annual, 2026-03-31) — Financing Cash Flow: 151149.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 121347.00
APLI.TO cash_flow (annual, 2026-03-31) — Free Cash Flow: -1337412.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -291845.00
APLI.TO income_statement (annual, 2026-03-31) — Gain On Sale Of Security: 213108.00
APLI.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -177244.00
APLI.TO income_statement (annual, 2026-03-31) — General And Administrative Expense: 2474750.00
APLI.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 994333.00
APLI.TO income_statement (annual, 2026-03-31) — Interest Expense: 1716703.00
APLI.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 1070884.00
APLI.TO income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 1716703.00
APLI.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1070884.00
APLI.TO income_statement (annual, 2026-03-31) — Interest Income: 0.00
APLI.TO income_statement (quarterly, 2026-03-31) — Interest Income: 0.00
APLI.TO income_statement (annual, 2026-03-31) — Interest Income Non Operating: 0.00
APLI.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 0.00
APLI.TO cash_flow (annual, 2026-03-31) — Interest Paid Cff: -46673.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: 26871.00
APLI.TO balance_sheet (annual, 2026-03-31) — Invested Capital: -4395225.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: -4395225.00
APLI.TO cash_flow (annual, 2026-03-31) — Investing Cash Flow: 0.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 0.00
APLI.TO cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 277500.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 100000.00
APLI.TO cash_flow (annual, 2026-03-31) — Issuance Of Debt: 0.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
APLI.TO balance_sheet (annual, 2026-03-31) — Long Term Debt: 671500.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 671500.00
APLI.TO balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 671500.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 671500.00
APLI.TO cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 0.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
APLI.TO cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -57378.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 2576.00
APLI.TO cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 277500.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 100000.00
APLI.TO balance_sheet (annual, 2026-03-31) — Net Debt: 12896262.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Net Debt: 12896262.00
APLI.TO cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -213107.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 193569.00
APLI.TO income_statement (annual, 2026-03-31) — Net Income: -4240740.00
APLI.TO income_statement (quarterly, 2026-03-31) — Net Income: -1049067.00
APLI.TO income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -4240740.00
APLI.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -1049067.00
APLI.TO income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -4240739.00
APLI.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -1049066.00
APLI.TO income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -4240740.00
APLI.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -1049067.00
APLI.TO income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -4240740.00
APLI.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -1049067.00
APLI.TO cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: -4240740.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -1049067.00
APLI.TO income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -4240739.00
APLI.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -1049066.00
APLI.TO income_statement (annual, 2026-03-31) — Net Interest Income: -1013008.00
APLI.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -367189.00
APLI.TO cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -57378.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 2576.00
APLI.TO cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -57378.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 2576.00
APLI.TO income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -1013008.00
APLI.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -367189.00
APLI.TO cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -22300.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -8100.00
APLI.TO balance_sheet (annual, 2026-03-31) — Net PPE: 10959.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 10959.00
APLI.TO cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: 0.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 0.00
APLI.TO balance_sheet (annual, 2026-03-31) — Net Tangible Assets: -17331490.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -17331490.00
APLI.TO income_statement (annual, 2026-03-31) — Normalized EBITDA: -2623708.00
APLI.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 241257.00
APLI.TO income_statement (annual, 2026-03-31) — Normalized Income: -4368604.80
APLI.TO income_statement (quarterly, 2026-03-31) — Normalized Income: -942720.60
APLI.TO cash_flow (annual, 2026-03-31) — Operating Cash Flow: -1337412.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -291845.00
APLI.TO cash_flow (annual, 2026-03-31) — Operating Gains Losses: -213107.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 193569.00
APLI.TO income_statement (annual, 2026-03-31) — Operating Income: -3821142.00
APLI.TO income_statement (quarterly, 2026-03-31) — Operating Income: -949317.00
APLI.TO income_statement (annual, 2026-03-31) — Operating Revenue: 244179.00
APLI.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 25263.00
APLI.TO balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 132366120.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 132366120.00
APLI.TO balance_sheet (annual, 2026-03-31) — Other Equity Interest: 651719.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 651719.00
APLI.TO income_statement (annual, 2026-03-31) — Other Gand A: 2474750.00
APLI.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 994333.00
APLI.TO income_statement (annual, 2026-03-31) — Other Income Expense: 698763.00
APLI.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: 308411.00
APLI.TO cash_flow (annual, 2026-03-31) — Other Non Cash Items: 960984.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 255151.00
APLI.TO income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 485655.00
APLI.TO income_statement (annual, 2026-03-31) — Other Operating Expenses: -2698184.00
APLI.TO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: -1939365.00
APLI.TO balance_sheet (annual, 2026-03-31) — Other Receivables: 1749423.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 1749423.00
APLI.TO balance_sheet (annual, 2026-03-31) — Payables: 6368644.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Payables: 6368644.00
APLI.TO balance_sheet (annual, 2026-03-31) — Payables And Accrued Expenses: 6368644.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 6368644.00
APLI.TO balance_sheet (annual, 2026-03-31) — Prepaid Assets: 120603.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 120603.00
APLI.TO income_statement (annual, 2026-03-31) — Pretax Income: -4135387.00
APLI.TO income_statement (quarterly, 2026-03-31) — Pretax Income: -1008095.00
APLI.TO cash_flow (annual, 2026-03-31) — Purchase Of PPE: 0.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: 0.00
APLI.TO balance_sheet (annual, 2026-03-31) — Receivables: 1801854.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 1801854.00
APLI.TO income_statement (annual, 2026-03-31) — Reconciled Depreciation: 8084.00
APLI.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1224.00
APLI.TO cash_flow (annual, 2026-03-31) — Repayment Of Debt: -57378.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 2576.00
APLI.TO income_statement (annual, 2026-03-31) — Research And Development: 4288755.00
APLI.TO income_statement (quarterly, 2026-03-31) — Research And Development: 1919612.00
APLI.TO balance_sheet (annual, 2026-03-31) — Retained Earnings: -75958548.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -75958548.00
APLI.TO income_statement (annual, 2026-03-31) — Selling General And Administration: 2474750.00
APLI.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 994333.00
APLI.TO balance_sheet (annual, 2026-03-31) — Share Issued: 132366120.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 132366120.00
APLI.TO cash_flow (annual, 2026-03-31) — Stock Based Compensation: 51390.00
APLI.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 10620.00
APLI.TO balance_sheet (annual, 2026-03-31) — Stockholders Equity: -17331490.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -17331490.00
APLI.TO balance_sheet (annual, 2026-03-31) — Tangible Book Value: -17331490.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -17331490.00
APLI.TO income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 85243.20
APLI.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -70897.60
APLI.TO income_statement (annual, 2026-03-31) — Tax Provision: 105352.00
APLI.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 40971.00
APLI.TO income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
APLI.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
APLI.TO balance_sheet (annual, 2026-03-31) — Taxes Receivable: 52431.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 52431.00
APLI.TO balance_sheet (annual, 2026-03-31) — Total Assets: 1973419.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 1973419.00
APLI.TO balance_sheet (annual, 2026-03-31) — Total Capitalization: -16659990.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -16659990.00
APLI.TO balance_sheet (annual, 2026-03-31) — Total Debt: 12936265.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 12936265.00
APLI.TO balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: -17331490.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -17331490.00
APLI.TO income_statement (annual, 2026-03-31) — Total Expenses: 4065321.00
APLI.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 974580.00
APLI.TO balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 19304909.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 19304909.00
APLI.TO balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 10959.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 10959.00
APLI.TO balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 671500.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 671500.00
APLI.TO income_statement (annual, 2026-03-31) — Total Other Finance Cost: -703695.00
APLI.TO balance_sheet (annual, 2026-03-31) — Total Tax Payable: 64746.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 64746.00
APLI.TO income_statement (annual, 2026-03-31) — Total Unusual Items: 213108.00
APLI.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: -177244.00
APLI.TO income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 213108.00
APLI.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -177244.00
APLI.TO balance_sheet (annual, 2026-03-31) — Working Capital: -16670949.00
APLI.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: -16670949.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -8594900000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 7983900000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -333300000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 6440600000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 610900000.00
APLLTD.NS cash_flow (annual, 2022-03-31) — Common Stock Issuance: 0.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 64100000.00
APLLTD.NS cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: 0.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 9687500000.00
APLLTD.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 2109800000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 1548200000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 8404600000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Hedging Assets Current: 145700000.00
APLLTD.NS income_statement (annual, 2022-03-31) — Interest Income: 17300000.00
APLLTD.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 17300000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 542400000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Investmentsin Joint Venturesat Cost: 4800000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Investmentsin Subsidiariesat Cost: 4500000.00
APLLTD.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 0.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 1278500000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 0.00
APLLTD.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -3000000000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 14245400000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Minority Interest: 0.00
APLLTD.NS income_statement (annual, 2022-03-31) — Minority Interests: 247500000.00
APLLTD.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 0.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 0.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 348800000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 1548200000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 610700000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Other Payable: 2135500000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 3348600000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
APLLTD.NS cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: 73000000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 4912000000.00
APLLTD.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -3000000000.00
APLLTD.NS income_statement (annual, 2022-03-31) — Research And Development: 505900000.00
APLLTD.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 83400000.00